Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVR
NCT ID: NCT00921466
Last Updated: 2009-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2009-06-30
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Piloting IVR (Interactive Voice Response) for Chronic Pain Treatment
NCT00651924
Interactive Voice Response (IVR)-Based Treatment for Chronic Low Back Pain
NCT01025752
Evaluation of Information Displays-A Paper, Computer and Simulator Based Study
NCT00714012
Formative Evaluation in Implementation Research: Guideline Development
NCT00683540
Evaluation of Self-Mediated Alternatives for Risk Testing Education and Return of Results
NCT06459583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospital Patients/Hospital Employees
No interventions assigned to this group
Hospital employees
A group of 10 hospital employees used as baseline
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Control subjects will be excluded for any MINI lifetime MDD or dysthymia diagnosis of a DSM-IV disorder except for specific phobia or dependence on nicotine and caffeine.
* Inpatients not admitted with suicidal ideations
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Rogers Center for Research & Training, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rogers Center for Research and Training, Inc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John H Greist, MD
Role: PRINCIPAL_INVESTIGATOR
Rogers center for Research and Training, Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rogers Center for Research and Training, Inc
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
113235
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.